[{"NetIncomeLoss_1_Q2_USD":-12391000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.917,"InterestPaidNet_2_Q2_USD":42000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":57000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.015,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.005,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":41894000.0,"AssetsCurrent_0_Q2_USD":173950000.0,"StockRepurchasedDuringPeriodShares_2_Q2_shares":5169.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2540028.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":731000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":694000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-8000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.917,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":57000.0,"CommonStockSharesIssued_0_Q2_shares":27184824.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":24416000.0,"Assets_0_Q2_USD":184510000.0,"ShareBasedCompensation_2_Q2_USD":1582000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":4594000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":4032354.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":93875000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":5.38,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":848000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"IncomeTaxesPaidNet_2_Q2_USD":1000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_Q2_shares":79823.0,"AccruedLiabilitiesCurrent_0_Q2_USD":5223000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ResearchAndDevelopmentExpense_1_Q2_USD":8596000.0,"ProceedsFromStockPlans_2_Q2_USD":132000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":3000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":673000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":94733000.0,"GainOnSaleOfInvestments_2_Q2_USD":3000.0,"RestrictedCash_0_Q2_USD":106000.0,"FinancialLiabilitiesFairValueDisclosure_0_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-24442000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-12334000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":191000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-2000.0,"OtherAssetsNoncurrent_0_Q2_USD":26000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":5010000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":288923000.0,"Liabilities_0_Q2_USD":12452000.0,"InvestmentOwnedAtCost_0_Q2_USD":171888000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"MarketableSecuritiesCurrent_0_Q2_USD":22871000.0,"DepreciationAndAmortization_2_Q2_USD":700000.0,"DepreciationAndAmortization_1_Q2_USD":400000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":7446000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":3994000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":20626139.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":21001730.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":147543000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":17622000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q2_shares":68949.0,"OperatingIncomeLoss_1_Q2_USD":-12590000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":57000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-8000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":57000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":1582000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":824000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-23151000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":1545000.0,"LiabilitiesCurrent_0_Q2_USD":7426000.0,"AccountsPayableCurrent_0_Q2_USD":952000.0,"NonoperatingIncomeExpense_2_Q2_USD":634000.0,"NonoperatingIncomeExpense_1_Q2_USD":199000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":147649000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3186000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3536000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.867,"ProceedsFromStockOptionsExercised_2_Q2_USD":726000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":258000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.004,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.004,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":132000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":132000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":253000.0,"DividendsCommonStock_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":4289000.0,"NetIncomeLoss_2_Q2_USD":-24434000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.849,"OperatingIncomeLoss_2_Q2_USD":-25068000.0,"InvestmentsFairValueDisclosure_0_Q2_USD":171945000.0,"RestrictedCashNoncurrent_0_Q2_USD":106000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":184510000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1686000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1582000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":824000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":8300000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":7475000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1206000.0,"OperatingExpenses_2_Q2_USD":25068000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":26246000.0,"OperatingExpenses_1_Q2_USD":12590000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.18,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.59,"ProfitLoss_2_Q2_USD":-24434000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":16000.0,"OtherLiabilitiesCurrent_0_Q2_USD":45000.0,"StockholdersEquity_0_Q2_USD":172058000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":69000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":24359000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-31000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-116925000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":113476000.0,"CommonStockSharesOutstanding_0_Q2_shares":27184824.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-251000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":900000.0,"Ticker":"IDYA","CIK":"1676725","name":"IDEAYA BIOSCIENCES, INC.","OfficialName":"IDEAYA Biosciences Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"410221098.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200812"}]